Sydney Lupkin
Stories
-
National
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
-
Medical Treatments
The FTC has filed a lawsuit over the artificially inflation of the price of insulin
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
-
Health
Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions
The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.
-
Business
Drug makers including Pfizer are starting to sell drugs directly to consumers
In a move that might allow them to sell drugs directly to patients, some drugmakers are getting into the telehealth business.
-
Health Care
Drug makers including Pfizer are starting to sell drugs directly to consumers
Some drugmakers are getting into the telehealth business in a move that might allow them to sell drugs directly to patients.
-
Health
Medicare negotiated lower prices on several drugs. What does that mean for patients?
For six of the 10 drugs that Medicare negotiated to lower prices, the net prices aren't any better than the ones insurers already get. But there may be a change in patients' choices of medicines.
-
Politics
Biden and Harris celebrate 'landmark' move to lower prescription drug prices
President Biden and Vice President Harris are using their first recent joint appearance to talk about prescription drug prices.
-
Health
Medicare negotiated drug prices for the first time. Here’s what it got
The White House announced new Medicare drug prices for 10 medicines popular with beneficiaries. It's the first time the federal program has negotiated lower prices with the pharmaceutical industry.
-
Health
The Biden administration is wrapping up negotiations to lower prescription drug prices
The first price negotiations between Medicare and drug companies has been underway since February. What do we know about how it's going?
-
Health
Torrid market for copycat weight loss drugs could be short-lived
Cheaper versions of Wegovy and Zepbound touted on social media could be fleeting. Copies are legal now because the brand-name drugs are in short supply. But the drugmakers are boosting production.
